4 December 2018 in International Journal of Nursing Practice
1 June 2017 in European Journal of Emergency Medicine
The aim of the study was to identify covariates associated with 28-day mortality in septic patients admitted to the emergency department and derive and validate a score that stratifies mortality risk utilizing parameters that are readily available. Patients with an admission diagnosis of suspected or confirmed infection and fulfilling at least two criteria for severe inflammatory response syndrome were included in this study. Patients’ characteristics, vital signs, and laboratory values were used to identify prognostic factors for mortality. A scoring system was derived and validated. The primary outcome was the 28-day mortality rate. A total of 440 patients were included in the study. The 28-day hospital mortality rate was 32.4 and 25.2% for the derivation (293 patients) and validation (147 patients) sets, respectively. Factors associated with a higher mortality were immune-suppressed state (odds ratio 4.7; 95% confidence interval 2.0–11.4), systolic blood pressure on arrival less than 90 mmHg (3.8; 1.7–8.3), body temperature less than 36.0°C (4.1; 1.3–12.9), oxygen saturation less than 90% (2.3; 1.1–4.8), hematocrit less than 0.38 (3.1; 1.6–5.9), blood pH less than 7.35 (2.0; 1.04–3.9), lactate level more than 2.4 mmol/l (2.27; 1.2–4.2), and pneumonia as the source of infection (2.7; 1.5–5.0). The area under the receiver operating characteristic curve was 0.81 (0.75–0.86) in the derivation and 0.81 (0.73–0.90) in the validation set. The SPEED (sepsis patient evaluation in the emergency department) score performed better (P=0.02) than the Mortality in Emergency Department Sepsis score when applied to the complete study population with an area under the curve of 0.81 (0.76–0.85) as compared with 0.74 (0.70–0.79). The SPEED score predicts 28-day mortality in septic patients. It is simple and its predictive value is comparable to that of other scoring systems.
2 January 2013 in European Journal of Cardiovascular Nursing
Poor adherence is a significant nursing and public health concern because it affects patients’ quality of life. It compounds the disease burden of the growing coronary heart disease population. Promoting optimal patient adherence to cardiac-health enhancing recommendations by healthcare providers can reduce mortality and morbidity risk after acute coronary syndrome (ACS). This paper sought to examine rates and predictors of patient adherence to health recommendations after ACS. A cross-sectional survey of 210 Malaysian patients using consecutive sampling was conducted in early 2009 at a tertiary teaching hospital. The Medical Outcome Study Specific Adherence Scale (MOSSAS) questionnaire was adapted to measure the extent of patient adherence to recalled health recommendations. Logistic regression modelling was applied to determine odds ratio and factors of suboptimal adherence. The suboptimal adherence rate was 65.2% (95% CI 58.8–71.7%). Recall of recommendation rates varied from 38.1% to 95.3%, whereas the adherence rates varied from 22.1% to 95.1% across the six aspects of health recommendation namely medication taking, dietary modification, regular physical exercise, stress reduction, gathering social support and avoidance of substance abuse. Those who had to adhere to more than three aspects of recommendations, active smokers and the Malay ethnic race had higher odds of suboptimal adherence. Monitoring of patient recall and adherence rate may provide information on the effectiveness of patient care management and outcomes. Identifying patients with higher risk for poor adherence is recommended for more targeted interventions.
22 December 2015 in Clinical Autonomic Research
28 February 2025 in Journal of Asian Pacific Society of Cardiology
AGAbdul Kahar Abdul Ghapar
+10
Background: Three main phenotypes describe heart failure (HF) according to left ventricular ejection fraction (LVEF). This study aims to describe the characteristics, management and outcomes of hospitalised patients with HF categorised by LVEF. Methods: The Malaysian National Heart Failure (MY-HF) Registry is a 3-year prospective, observational study of patients admitted for acute HF. This analysis includes 2,651 patients categorised into: HF with reduced ejection fraction (HFrEF; LVEF ≤40%), HF with mildly reduced ejection fraction (HFmrEF; LVEF 41−49%) and HF with preserved ejection fraction (HFpEF; LVEF ≥50%). Hospital readmission and mortality outcomes at 30 days and 1 year were examined. Results: The HFrEF subgroup represented the largest proportion of patients (66.2%), followed by HFpEF (22.1%) and HFmrEF (11.7%). The HFpEF subgroup was older (mean age 65.3 ± 13.3 years), had the highest proportion of females (53.5%) and had more patients with de novo HF at admission than the HFrEF subgroup (41.9% versus 31.4%). Comorbidities, such as hypertension, AF and chronic kidney disease, were more prevalent in the HFpEF than HFrEF subgroup. Conversely, more HFrEF patients had ischaemic heart disease and elevated N-terminal pro B-type natriuretic peptide levels (≥1,000 pg/ml). Similar 30-day and 1-year outcome rates were observed across the subgroups except for lower 30-day hospital readmission (p=0.024) and 1-year mortality (p=0.005) in the HFpEF subgroup. Older age (>60 years) and New York Heart Association class III–IV increased 1-year readmission risk. Conclusion: The MY-HF Registry highlighted high 1-year mortality in patients with HF, especially those with advanced NYHA class or chronic kidney disease. This suggests potential areas for improvement in HF management, including medication regimens, adherence and comorbidity management. Future research exploring these factors could significantly impact clinical practice and patient outcomes.